235 related articles for article (PubMed ID: 30278257)
1. Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets.
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Jan; 554():54-60. PubMed ID: 30278257
[TBL] [Abstract][Full Text] [Related]
2. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
3. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
4. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissolution of sildenafil citrate as dry foam tablets.
Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
[TBL] [Abstract][Full Text] [Related]
6. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
Figueroa CE; Bose S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1046-55. PubMed ID: 23916460
[TBL] [Abstract][Full Text] [Related]
7. Spray drying of naproxen and naproxen sodium for improved tableting and dissolution - physicochemical characterization and compression performance.
Al-Zoubi N; Odeh F; Partheniadis I; Gharaibeh S; Nikolakakis I
Pharm Dev Technol; 2021 Feb; 26(2):193-208. PubMed ID: 33211618
[TBL] [Abstract][Full Text] [Related]
8. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
9. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
10. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
11. A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance.
Al-Khattawi A; Koner J; Rue P; Kirby D; Perrie Y; Rajabi-Siahboomi A; Mohammed AR
Eur J Pharm Biopharm; 2015 Aug; 94():1-10. PubMed ID: 25960332
[TBL] [Abstract][Full Text] [Related]
12. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
13. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
14. Can spray freeze-drying improve the re-dispersion of crystalline nanoparticles of pure naproxen?
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Jun; 564():293-298. PubMed ID: 31022500
[TBL] [Abstract][Full Text] [Related]
15. Effects of pH of processing-medium on re-dispersion of spray dried, crystalline nanoparticles of pure naproxen.
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Mar; 558():261-267. PubMed ID: 30641175
[TBL] [Abstract][Full Text] [Related]
16. Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen.
Čerpnjak K; Pobirk AZ; Vrečer F; Gašperlin M
Int J Pharm; 2015 Nov; 495(1):336-346. PubMed ID: 26341323
[TBL] [Abstract][Full Text] [Related]
17. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
18. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
19. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
[TBL] [Abstract][Full Text] [Related]
20. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.
Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
Drug Dev Ind Pharm; 2015; 41(9):1548-57. PubMed ID: 25308746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
